(Q42127606)

English

Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma

scientific article published on 8 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma (English)

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lana Bijelic

1

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

O Anthony Stuart

2

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Paul Sugarbaker

3

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

publication date

8 August 2012

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Gastroenterology research and practice

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

2012

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

890450

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

A review of peritoneal mesothelioma at the Washington Cancer Institute

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

Clinical presentation of peritoneal mesothelioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

Peritoneal mesothelioma: treatment approach based on natural history.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

New strategies are needed in diffuse malignant mesothelioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

29 May 2018

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

17 August 2018

Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

17 August 2018

Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

17 August 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

17 August 2018

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3423889

17 August 2018

Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multimodality therapy for malignant mesothelioma based on a study of natural history

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective trial for the treatment of malignant peritoneal mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse malignant mesothelioma of the peritoneum

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22927839

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2012/890450

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42127606&oldid=1934106467"